Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Nov 27;69(12):2234-2235.
doi: 10.1093/cid/ciz376.

Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?

Shilpa R Jain  1 , Pakpoom Phoompoung  1   2 , Shahid Husain  1
Affiliations
Comment

Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?

Shilpa R Jain et al. Clin Infect Dis. .
No abstract available

Keywords: respiratory syncytial virus; ribavirin; transplant.

PubMed Disclaimer

Comment in

  • Reply to Jain et al.
    Foolad F, Chemaly RF. Foolad F, et al. Clin Infect Dis. 2019 Nov 27;69(12):2235-2236. doi: 10.1093/cid/ciz379. Clin Infect Dis. 2019. PMID: 31074774 No abstract available.

Comment on

References

    1. Foolad F, Aitken SL, Shigle TL, et al. . Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients. Clin Infect Dis 2018; doi:10.1093/cid/ciy760. - DOI - PMC - PubMed
    1. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013;56:258–66. - PMC - PubMed
    1. Shah DP, Ghantoji SS, Shah JN, et al. . Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother 2013; 68:1872–80. - PMC - PubMed
    1. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 2011; 117:2755–63. - PubMed
    1. Shah DP, Ghantoji SS, Ariza-Heredia EJ, et al. . Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood 2014; 123:3263–8. - PMC - PubMed